Aster DM Quality Care Q1 FY27 Results: Net Loss of ₹14.30 Crore
Aster DM Quality Care reported a standalone net loss of ₹14.30 crore for Q1 FY27, a significant drop from a profit of ₹80.59 crore in Q1 FY26. Total income rose to ₹764.76 crore. The company incurred ₹109.79 crore in exceptional merger-related expenses. Investments totaling ₹101.49 crore were made in subsidiaries and associates.
The net loss and significant exceptional expenses due to the merger are material events that could impact investor sentiment and the company's short-term financial performance.
The company reported a net loss for the quarter, a significant decrease in profitability compared to the previous year, driven by exceptional merger-related expenses.
Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) announced its unaudited financial results for the first quarter ended 30 June 2026. The Board of Directors approved the standalone and consolidated financial results at a meeting held on 5 August 2026. The meeting commenced at 11:30 AM (IST) and concluded at 04:40 PM (IST).
For the quarter ended 30 June 2026, the company reported a standalone net loss of ₹14.30 crore, compared to a profit of ₹80.59 crore in the same quarter last year. Total income for the quarter stood at ₹764.76 crore, a slight increase from ₹651.47 crore in the prior year period. Expenses increased to ₹644.08 crore from ₹539.05 crore, primarily due to merger-related expenses amounting to ₹109.79 crore, which were classified as exceptional items.
The company also reported consolidated results, which include the financial information of subsidiaries and associates. The consolidated net loss for the quarter was ₹4.41 crore. The company's name was officially changed from Aster DM Healthcare Limited to Aster DM Quality Care Limited effective 1 July 2026, following the National Company Law Tribunal's sanction of the amalgamation scheme.
Additionally, the company made several investments during the quarter. An investment of ₹45.09 crore was made in Aster DM-Super Specialty Hospital (Sarjapur) Private Limited, a wholly owned subsidiary. An investment of ₹25.00 crore was made in Optionally Convertible Redeemable Preference Shares (OCRPS) in Alfaone Medicals Private Limited, an associate. The company also acquired an additional 1.54% stake in its subsidiary Malabar Institute of Medical Sciences Limited for ₹31.40 crore, increasing its shareholding to 81.29%. The unaudited financial results have been reviewed by M/s. Deloitte Haskins & Sells, Statutory Auditors.
What to do with a filing like this
Aster DM Quality Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Quality Care Limited. Read the original for the full detail.